Ngā hua rapu - Relecom, Allan

Emerging dynamics pathways of response and resistance to PD-1 and CTLA-4 blockade: tackling uncertainty by confronting complexity mā Relecom, Allan, Merhi, Maysaloun, Inchakalody, Varghese, Uddin, Shahab, Rinchai, Darawan, Bedognetti, Davide, Dermime, Said

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Screening Status as a Determinant of Choice of Colorectal Cancer Screening Method: A Population-Based Informed Survey mā Sandoval, José Luis, Relecom, Allan, Ducros, Cyril, Bulliard, Jean-Luc, Arzel, Beatrice, Guessous, Idris

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Unleashing the immune response to NY-ESO-1 cancer testis antigen as a potential target for cancer immunotherapy mā Raza, Afsheen, Merhi, Maysaloun, Inchakalody, Varghese Philipose, Krishnankutty, Roopesh, Relecom, Allan, Uddin, Shahab, Dermime, Said

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Resources-Stratified Guidelines for Classical Hodgkin Lymphoma mā Relecom, Allan, Federico, Massimo, Connors, Joseph M., Coiffier, Bertrand, Biasoli, Irene, Moccia, Alden, Salles, Gilles, McKee, Thomas, Miralbell, Raymond, Borchmann, Peter, Kuruvilla, John, Johnson, Peter, Cavalli, Franco, Delavy, Martine, Dietrich, Pierre-Yves, Flahault, Antoine

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Persistent anti-NY-ESO-1-specific T cells and expression of differential biomarkers in a patient with metastatic gastric cancer benefiting from combined radioimmunotherapy treatmen... mā Merhi, Maysaloun, Raza, Afsheen, Inchakalody, Varghese Philipose, Siveen, Kodappully S, Kumar, Deepak, Sahir, Fairooz, Mestiri, Sarra, Hydrose, Shereena, Allahverdi, Niloofar, Jalis, Munir, Relecom, Allan, Al Zaidan, Lobna, Hamid, Mohamed Sir Elkhatim, Mostafa, Mai, Gul, Abdul Rehman Zar, Uddin, Shahab, Al Homsi, Mohammed, Dermime, Said

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa